2004
DOI: 10.1016/j.jclinane.2003.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Nicardipine versus nitroprusside for deliberate hypotension during idiopathic scoliosis repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
17
0
2

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 29 publications
0
17
0
2
Order By: Relevance
“…Prior studies of SNP have primarily examined: 1) clinical outcomes secondary to BP changes, such as amount of blood loss, recovery time, etc. ; 3,8,9 or 2) physiologic features such as cerebral oxygenation, mixed venous oxygen saturation, or rebound tachycardia. [15][16][17][18] There are no data describing how the practice of deliberate hypotension varies with respect to time spent in satisfactory BP control and the frequency and magnitude of dose titrations necessary to achieve said control.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior studies of SNP have primarily examined: 1) clinical outcomes secondary to BP changes, such as amount of blood loss, recovery time, etc. ; 3,8,9 or 2) physiologic features such as cerebral oxygenation, mixed venous oxygen saturation, or rebound tachycardia. [15][16][17][18] There are no data describing how the practice of deliberate hypotension varies with respect to time spent in satisfactory BP control and the frequency and magnitude of dose titrations necessary to achieve said control.…”
Section: Discussionmentioning
confidence: 99%
“…In comparison to other BP-decreasing drugs, SNP has both faster onset and offset of effect. 8,9 These properties allow for rapid adjustment of drug dosing in response to BP changes from various clinical factors. Neither hepatic nor renal dysfunction are contraindications for SNP use.…”
Section: Introductionmentioning
confidence: 99%
“…In comparison to other BP-decreasing drugs, SNP has both faster onset and offset of effect. 8,9 These properties allow for rapid adjustment of drug dosing in response to BP changes from various clinical factors. Neither hepatic nor renal dysfunction are contraindications for SNP use.…”
Section: Introductionmentioning
confidence: 99%
“…Esmolol is an ultrashort-acting β-adrenoceptor blocker, which can reduce the heart rate, prolong coronary perfusion, and increase subendocardial blood flow [26][27][28][29][30] . Vasoactive therapeutic agents such as combinations of esmolol with nicardipine or nitroglycerin are often used to maintain hemodynamic stability and associated with a decrease in stress responses in the perioperative period [24][25][26][27][28][29][30] . However, it remains unclear whether the combined use of esmolol with either nicardipine or nitroglycerin to maintain hemodynamic stability affects the incidence of POCD in elderly patients after surgery.…”
mentioning
confidence: 99%